26.12.2013 Views

postmenopozal dönemdeki kadınlara uygulanan hormon tedavisi ve ...

postmenopozal dönemdeki kadınlara uygulanan hormon tedavisi ve ...

postmenopozal dönemdeki kadınlara uygulanan hormon tedavisi ve ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

35) Blavias JG, Awad Sa, Bıssada N. Urodynamic Procedure Recommendations Of The Urodynamic<br />

Socıety Procedure That Should Available For Routıne Urologıc Practice. Neurourol Urodynamics. 1998: 1-<br />

51.<br />

36) Heritz DM , Blaivas JG. Reliability and specifity of the leak point pressure. J Urol 1995; (153) :492.<br />

37) Brubaker LT, Sand PK. Cystometry Uretrocystometry And Sideourethrography. Clin. Obstet Gynecol.<br />

1990; 33(2) :315-324.<br />

38) Jeter KF. Pelvic Floor Muscle Exercises With Or Without Biofeedback For The Treatment Of Stress<br />

ncontinence. Prob Urol. 1991; 5(1) :72-74.<br />

39) Olah KS, Bridges N, Denning J. The Conservati<strong>ve</strong> Management Of Patients With Symptoms Of Stress<br />

Urinary Incontinence Randomized Prospecti<strong>ve</strong> Study Comparing Vaginal Cones And nterferential Therapy.<br />

Am J Ob Gyn. 1990; 162 (1) :87-92.<br />

40) Sand K, Milllard RJ, Oldenburg BF. The Symptomatic Urodynamic And Psycodynamic Results Of<br />

Bladder Reeducation Programs. J Urol. 1983; (130) :715-719.<br />

41) Brubaker L, Benson JF, Bent A. Transvagininal Electrical Stimulation For Female Urinary<br />

ncontinence. Am J Ob Gyn. 1997; 177(3) :537-540.<br />

42) Anderson KY. The pharmacology of lower urinary tract smooth muscles and penile erectile<br />

tissues.Pharmacol Rev. 1993; (45) :253-308.<br />

43) Çetinel B. Aırı aktif mesanede farmakoterapi. Aktüel Tıp Dergisi. 2002; 7(7) : 34-43.<br />

44) Chappe CR. Muscarinic receptor antagonists in the treatment of o<strong>ve</strong>racti<strong>ve</strong> bladder. Urology.2000;<br />

55(Suppl 5 A) 47-49.<br />

45) Anderson KY. Pharmacological treatment of urinary incontinence. Aktüel Tıp Dergisi. 2002: 48-58.<br />

46) Nil<strong>ve</strong>rbrant L. Tolderodine new bladder-selecti<strong>ve</strong> antimuskarinic agent. Eur J Pharmacol. 1997; (327)<br />

:195-207.<br />

47) Höfner K. Tolerability and efficacy of trospium chloride in long –term treatment(52 weeks) in patients<br />

with urge syndrom: a double-blind, controlled, multicentre clinikal trial. Neurourol Urodyn. 2000;(19) : 487.<br />

48) Jüneman KP, Al-Shukri S. Eficacy and tolerability of trospiyum chloride and tolderodine in 234<br />

patients with urge syndrome: a double-blind, placebo controlled, multicentre clinicial trial. Neurourol<br />

Urodyn. 2000; (19) :488.<br />

49) Bump RC, Friedman CL. Intraluminal urethral pressure measurements in the female baboon. Effects of<br />

<strong>hormon</strong>al manipulation. J.Urol . 1986; (136) :508.<br />

50) Wein AJ. Pharmacology Of ncontinence. Urol Slin North Am. 1995; (22) :557-578.<br />

51) Levin RM, Shofer FS, Wein AJ. Estrojen induced alterations in the autonomic response of the rabbit<br />

ürinary bladder. J Pharmacol Exp Ther. 1980; (215) : 614.<br />

52) Levin RM, Zdenic SA,Ewalt DH. Effects of pregnancy on muscarinik receptor density and function in<br />

the rabbit urinary bladder. Pharmacology. 1991; (43) :69.<br />

79

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!